Shares of Willis Towers Watson Public Limited Company WTW have gained 14.5% in the past year, underperforming the industry and the Finance sector’s growth of 22.6% and 5.1%, respectively. Shares of WTW...
Shares of Arthur J. Gallagher & Co.’s AJG have gained 29.1% in the past year, outperforming its industry, the Finance sector and the Zacks S&P 500 composite’s return.Arthur J. Gallagher shares are...
/Marsh%20%26%20McLennan%20Cos_%2C%20Inc_%20NY%20HQ%20-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Marsh & McLennan will release its first-quarter earnings this month, and analysts anticipate a single-digit bottom-line growth.
Looking at Erie Indemnity’s recent outperformance relative to the Dow, analysts remain moderately optimistic about the stock’s prospects.
For Immediate ReleaseChicago, IL – March 25, 2025 – Today, Zacks Equity Research Equity areErie Indemnity Co. ERIE, Brown and Brown, Inc. BRO, Marsh & McLennan Companies MMC, Arthur J. Gallagher &...
The Zacks Insurance Brokerage industry is expected to benefit from better pricing, prudent underwriting, rising demand for insurance products and global expansion, which have been driving revenues. The...
/Willis%20Towers%20Watson%20Public%20Limited%20Co%20office%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
As Willis Towers Watson has outpaced the Dow recently, analysts remain moderately optimistic about the stock’s prospects.
Marsh & McLennan has exceeded the broader S&P Index’s performance over the past year, but analysts remain cautious about the stock’s prospects.
Due to Marsh & McLennan’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.